Introduction
A previously healthy 42-year-old caucasian male was The primary antiphospholipid antibody syndrome is a referred to our hospital for ARF. He had been well thrombophilic disorder in which the combination of until about 7 days earlier, when he first experienced a recurrent venous or arterial thrombosis and antiphos-transitory episode of low back pain; 3 days before his pholipid antibodies (anticardiolipin antibodies and/or admission he experienced another but severe episode lupus anticoagulant) occurs in patients without the of low back pain with nausea and vomiting during characteristic features of systemic lupus erythematosus light work. His blood pressure was 110/70 mmHg. The (SLE) [1] [2] [3] . The thrombosis can affect vessels of all results of ECG and ambulatory abdominal ultrasound sizes, the most consistent histopathological lesion being were normal. Abdominal colic was diagnosed, but the a bland thrombus without inflammation [4] .
pain did not improve after antispastic therapy. The mechanism of thrombosis is unknown. Recent
The patient was therefore admitted to a district studies have shown that a subset of phospholipid general hospital where non-oliguric ARF was diaantibodies reacts with the complex of phospholipid gnosed (serum creatinine concentration=7.93 mg/dl ). and serum b 2 -glycoprotein 1, the cofactor that inhibits The result of an ultrasound investigation of the abdomfactor XII and platelet activation, and prothrombinase inal organs was normal. The patient was then transactivity [5] . The membrane, a web or shelf of tissue ferred in our renal Unit. He complained of mild occluding the inferior vena cava, is seen in various abdominal pain and nausea. His body temperature pathological states, such as myeloproliferative dis-was 36.5°C, pulse rate 90 b.p.m., and blood pressure orders, disorders due to oral contraceptives, antiphos-130/70 mmHg. Tenderness and oedema were found in pholipid antibody syndrome, SLE, Beçhet's syndrome, the right leg. Examination of the lungs, heart, and pericaval filariasis, visceral thrombophlebitis migrans abdomen was unremarkable. [6 ] , and paroxysmal nocturnal haemoglobinuria [7] . The patient's past medical history included hyperbiliThe membranous obstruction of the inferior vena rubinaemia caused by Gilbert syndrome. cava is generally associated with Budd-Chiari syn-
The results of the laboratory evaluation are shown drome, since the outflow of venous hepatic blood is in Table 1 . Twenty-four hour urinary protein excretion generally obstructed in some way at various sites within was 0.5 g, and the patient presented microhaematuria. the inferior vena cava [8] , whereas acute renal failure He did not meet the criteria for SLE. Lupus anticoagu-(ARF ) is not usually present.
lant was positive and high levels of IgG anticardiolipin Renal involvement is also relatively infrequent in antibodies were detected. Colour-Doppler abdominal patients with antiphospholipid antibody syndrome ultrasonography showed thrombosis of the superficial without SLE and it may be due to renal thrombotic femoral, common femoral, external and common iliac right veins, as well as of the inferior vena cava just above the renal and just below the hepatic veins. The Correspondence and offprint requests to: Prof. Dr Francesco Locatelli, renal arteries were normal. Intravenous heparin Department of Nephrology and Dialysis, Azienda Ospedale di Lecco, Via Ghislanzoni 22, I-23900 Lecco, Italy.
therapy (1500 U/h) was started. After 7 days of treat- ment, renal function completely recovered and proteinuria improved. After 14 days of treatment, a venacavogram revealed a complete acute thrombosis of the inferior vena cava (Figure 1 ), whereas the renal veins were patent. Fig. 1 . Complete acute thrombosis of the inferior vena cava. Thrombolytic therapy was started with a local infusion of urokinase (200 000 U/h) into the clot and intravenous heparin therapy (1500 U/h). After 4 days of treat-and it is due to thrombotic complications of the ment, a further venacavogram showed the complete renal vessels. dissolution of the thrombus and partial patency of the We here present the case of a patient affected by inferior vena cava with a membranous septum membranous obstruction of the inferior vena cava due (Figure 2 ). The pressure gradient across the caval to antiphospholipid antibody syndrome with ARF that stenosis was 10 mmHg.
was successfully managed by means of angioplasty and Thrombolytic therapy was subsequently discon-thrombolytic therapy. tinued and repeated sessions of percutaneous translu-
The ARF was probably a haemodynamic complicaminal balloon angioplasty (PTA) were started (with tion of the inferior vena cava acute thrombosis, as we increasing balloon diameter: 10-12-15 mm).
found no thrombosis in the renal veins or arteries. Following this last procedure, the venacavogram However, the concomitant presence of another renal showed a complete resolution of the stenosis and a pathology cannot be excluded without performing a normal patency of the inferior vena cava ( Figure 3) . renal biopsy. The rapid improvement in renal function After dilatation, the pressure gradient decreased to and proteinuria supports the hypothesis of haemo-1 mmHg. The patient was started on anticoagulant dynamic damage. and antiplatelet therapy, and discharged. The laboratIn our case, appropriate thrombolytic therapy and ory evaluation is shown in Table 1 .
angioplasty probably avoided the proximal extension A follow-up venacavogram after 1 month confirmed of the thrombus and the onset of Budd-Chiari synthe normal patency of the inferior vena cava, as did drome, which has a high incidence of mortality. Local colour-Doppler imaging, at 6, 12 and 24 months. thrombolytic therapy completely dissolved the thrombus, and the venacavogram showed a membranous septum of the inferior vena cava.
Discussion
There are few data in the literature concerning the use of thrombolytic therapy for thrombosis of the inferior vena cava [7, 15, 16 ] . ARF is a rare complication of primary antiphospholipid antibody syndrome, a recognized cause of the Direct application of the thrombolytic agent into the clot through a catheter seems likely to be effective, membranous obstruction of the inferior vena cava, and has previously been claimed to be superior to The web of our patient was below the hepatic veins, systemic infusion in superior vena cava syndrome [17] .
and there was a large pressure gradient across it. The lytic agent should ideally be administered before Possibly the web could be a previous thrombus at this the organization of thrombus, otherwise the lysis of site, now organized, with partial obstruction of blood the thrombus is less likely to succeed. The main flow. thrombolytic agents used are urokinase, streptokinase, and tissue-type plasminogen activator. No studies have addressed the relative efficacy of these agents for the Conclusion thrombosis of the vena cava, and the choice of an agent for a specific patient depends on physician preference and costs. Haemorrhagic risks are minimized by Aggressive therapy is warranted for patients with acute membranous obstruction of the inferior vena cava direct application, because a lower dose than that used in systemic therapy can be administered.
due to antiphospholipid antibody syndrome in order to avoid the onset of Budd-Chiari syndrome. The cause of the acute thrombosis of the inferior vena cava in our patient was the membranous obstruc-Thrombolytic therapy and angioplasty seem to be the most logical combination because they are directed at tion of the inferior vena cava due to antiphospholipid antibody syndrome. It is still unknown whether the the site and cause of obstruction.
The risk of recurrent thrombosis in patients with the membranous obstruction of the inferior vena cava is congenital or acquired. Although there is a lack of antiphospholipid antibody syndrome is high [20] , and so long-term anticoagulation therapy is advisable. convincing data supporting a congenital origin, there is evidence showing that the webs are a result of the natural resolution of a thrombus. Histologically, the
